Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 15345143Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2026
Linked Award Amount
$1.2M
Full award amounts, FY2026
Award Records
1
Records listing this PI
Award-Linked Rank
#16,988
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Federico Cividini as a PI. Multi-PI records show the full award amount for context.
- 2R44HL167349-03R44CRI-103 gene therapy as Investigational New Drug for Dilated Cardiomyopathy$1.2Maward amount
Award organization
Organizations that administered FY2026 awards listing Federico Cividini as a PI.
FY2026 award administered by Cardiac Rsk3 Inhibitors, Llc (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardCardiac Rsk3 Inhibitors, Llc
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #5435
- 2026$2M Cumulative Funding